Dataset opportunity
Histosonics — 医疗影像数据集机会
Histosonics 持有的海量医疗影像数据集，可用于诊断人工智能和计算机视觉。
Score
81.6
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
92%
Action
数据共享协议
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
全球医疗诊断人工智能市场 = 2023 年为 16.4 亿美元，复合年增长率为 26.40%（来源：BlueWeave Consulting）
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Concrete evidence this company actively cares about data — why it's ripe for the deal room.
Profile
Dataset profile
Type
医疗影像数据集
Modality
图像
Sector
医疗保健
Volume
大型
Freshness
实时
Rarity
高（专有）
Accessibility
受限
Legal
公司所有 — GDPR 敏感（个人身份信息审查）
Buyer persona
医疗人工智能与诊断影像公司
Histosonics 拥有一个独特的医疗影像数据集，由专有的超声成像和治疗遥测数据组成，该数据集与 `medical_records` 和 `clinical trial` 协议的数据深度集成。这种丰富、多模态的集合提供了开发和验证强大的诊断人工智能算法（特别是针对新颖治疗应用）所需的高质量、经过精心策划的证据。
全球医疗诊断人工智能市场在 2023 年的估值为 16.4 亿美元，预计将以惊人的 26.40% 的复合年增长率增长。[5] 由于高度敏感的患者信息 (PHI) 以及其作为与监管文件相关的核心知识产权的性质，访问权限很复杂，但该数据集的稀有性和直接适用性使其成为抓住这一高增长市场份额的战略资产。⚠ 尽职调查（有价值的数据，可协商的访问权限）：高度敏感的医疗和患者健康信息 (PHI)，受 HIPAA/GDPR 管辖；数据与临床试验方案和监管文件相关；专有的超声成像和治疗遥测是核心知识产权。· 公司：独立。
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
这些证据共同证明 Histosonics 拥有一个专有的医学影像数据集，来自其用于新颖、非侵入性癌症治疗的临床试验。这是在快速增长的医疗诊断市场中训练诊断人工智能模型的宝贵资产，该市场正以每年超过 26% 的速度扩张。该数据集独特地将放射学肝脏肿瘤影像与来自公司 FDA 授权的聚焦超声平台特定患者结果和设备参数联系起来，为构建和验证下一代人工智能工具提供了难得的机会。
See dimension details ↓- Dataset Specificity100
主导的“medical_records”，医疗保健行业，4 种特定类型
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity70
专有领域数据（开放会降低稀有度）
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume100
15 个证据命中
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness82
实时/流式传输
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value94
适合诊断人工智能
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand90
人工智能买家需求异常高，这得益于对专有、经过临床验证的影像数据的需求，以在医疗诊断人工智能市场中竞争，该市场正以 26.40% 的复合年增长率扩张。[5]
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility26
开放/API 访问
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility50
高难度，独立
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength100
7 种证据类型，15 个命中
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License62
所有权=已拥有，许可=GDPR 敏感
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
独立
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation56
2 个数据胃口信号（2 种类型）
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
盈余=高，5 个近期外部信号 — 专有数据超出已货币化的部分
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit92
✓ 良好目标 — Histosonics 是一家医疗设备公司，其核心业务是销售 Edison System，一种使用聚焦超声进行非侵入性肿瘤破坏的机器；生成的成像和程序数据是其运营使用的副产品，而不是其主要产品。问题：该公司有 200-418 名员工，属于中型企业规模的较大范围。[3, 4, 8, 12]；它资金充足（已筹集超过 3 亿美元），最近被多数股权收购，表明它是一家成熟的高增长公司，而不是一家小型、未
- Deep Qualification90
⚠ 需要审查 — HistoSonics 是一家医疗设备公司，其核心业务是销售 Edison Histotripsy System，而不是数据。其设备运行和临床试验产生的超声成像和临床数据是高度受限的副产品，所有权在 HistoSonics（作为发起方）和临床地点/研究人员之间共享。[许可受限]
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
press
- “<figure><div><img src="https://imgproxy.divecdn.com/OoAzm3jhx9vjiV-ar0wQj8a67_zK-JTaFN4BJA6T1Ic/g:nowe:11:6/c:770:435/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9oaW5vdG9yaV9xQkkyQ1YwLmpwZw==.webp" /></div></figure><p>The Japanese medical robotics company, a joint venture between Kawasaki and Sysmex, is preparing for a European launch after expanding in the Asia-Pacific region.</p>”
- “<p>ForSight Robotics' JASPER Platform assists surgeons with cataract surgeries, while still leaving the power in the surgeon's hands.</p> <p>The post <a href="https://www.therobotreport.com/forsight-robotics-road-to-performing-a-fully-robotic-cataracts-surgery/">ForSight Robotics’ road to performing a fully robotic cataract surgery</a> appeared first on <a href="https://www.therobotreport.com">The Robot Report</a>.</p>”
- “<p>With the acquisition of Robocath completed, Stereotaxis intends to accelerate development of next-generation robotic technologies for endovascular procedures.</p>”
Downloads / exports
这些文件代表了正式临床研究的组合，提供了结构化的参考文献和试验信息，确立了影像数据的科学和监管出处。
Medical records / imaging
这是核心临床成像数据集的直接证据，包括来自关键试验的放射学影像，以及记录的患者队列和结果—这是训练诊断模型的必要真实依据。
Court documents
该文本证实了正式培训协议的存在，表明产生的数据是在标准化程序下生成的，这提高了其在人工智能模型训练中的可靠性。
API access
这种多模态证据指向可通过程序访问的结构化临床试验结果，提供了可用于大规模标记和验证相关影像数据的可量化成功指标。
Developer portal
公开的融资和战略投资公告证实了公司持续的商业化努力，确保了数据集与可行、市场相关的医疗设备相关联。
Image collection
此内容提供了解释聚焦超声过程独特视觉伪影的技术元数据，这对于人工智能正确解释成像特征至关重要。
IoT / sensor data
这种时间序列证据表明系统生成设备遥测数据，为丰富、多模态数据集提供了途径，该数据集将机器性能参数与成像结果和临床结果相关联。
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Histosonics Medical Imaging — a Large medical imaging dataset (Image modality) in the healthcare domain. Primary AI use-case: Diagnostic AI. Market signal: Global AI in medical diagnostics market = $1.64 billion in 2023, CAGR 26.40% (source: BlueWeave Consulting). Investment score 81.6/100 (confidence 0.92). Recommended action: Data Sharing Agreement.
From the marketplace
Explore live data opportunities
Store Dot — 工业运营数据集机会
View opportunity →工业Altris — 工业运营数据集机会
View opportunity →工业Fmb Maschinenbau — 维护日志数据集商机
View opportunity →